Improvement of erythropoiesis in uremic patients on CAPD.
Chronic renal failure anemia noticeably improves only in patients who undergo CAPD treatment. In order to understand why it is so, the behaviour of some hematological parameters and the weekly clearances of creatinine and peak 7c1 were studied in the course of hemodialysis (HD) and CAPD. Our study shows that an improvement in hematological data is obtained in patients undergoing CAPD but not in those undergoing HD: this result is directly correlated with the increase of the peak 7c1 weekly clearance. Since the serum erythropoietin values are not modified, the improvement of the anemia appears to be related to the reduction of the biochemical abnormality of uremia using a better qualitative or quantitative depuration of bone marrow activity inhibitory material by CAPD.
D000328:Adult; D003404:Creatinine / Q000097:blood / Q000378:metabolism; D004906:Erythrocyte Count; D004920:Erythropoiesis; D004921:Erythropoietin / Q000097:blood; D005260:Female; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis; D010531:Peritoneal Dialysis, Continuous Ambulatory; D006435:Renal Dialysis; D012156:Reticulocytes; D014511:Uremia / Q000097:blood* / Q000503:physiopathology
D006454:Hemoglobins; D004921:Erythropoietin; D003404:Creatinine